Novel amino acid Schiff base Zn(II) complexes as new therapeutic approaches in diabetes and Alzheimer's disease: Synthesis, characterization, biological evaluation, and molecular docking studies
 
Yazarlar (6)
Doç. Dr. Ayşegül ŞENOCAK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Nilay A. Taş
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Doç. Dr. Parham Taslimi Bartin Üniversitesi, Türkiye
Prof. Dr. Burak Tüzün Cumhuriyet Üniversitesi, Türkiye
Doç. Dr. Ali Aydin Yozgat Bozok University, Türkiye
Ahmet Karadağ Yozgat Bozok University, Türkiye
Makale Türü Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Journal of Biochemical and Molecular Toxicology (Q3)
Dergi ISSN 1095-6670 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 03-2022
Cilt / Sayı / Sayfa 36 / 3 / 22969–0 DOI 10.1002/jbt.22969
Makale Linki http://dx.doi.org/10.1002/jbt.22969
UAK Araştırma Alanları
Anorganik Kimya
Özet
Schiff bases are compounds that have gained importance in the paint industry due to their colorful nature and in the field of chemistry and biochemistry due to their biological activities. Various biological applications of Schiff bases, such as antitumor, antifungal, antibacterial, antioxidant, antituberculosis, and anthelmintic, have been widely studied. Within the scope of the study, 5‐bromo‐2‐hydroxybenzaldehyde and amino acid methyl esters (isoleucine, phenylalanine, and methionine) and amino acid Schiff bases were synthesized first. The synthesis of the new Zn(II) complexes of these Schiff bases was carried out by the reaction of synthesized Schiff bases and Zn(OAc)2·2H2O. The structures of the synthesized complexes were elucidated using elemental analysis, Fourier transform infrared, nuclear magnetic resonance, UV‐visible, and thermal analysis spectroscopy techniques. These synthesized salts were …
Anahtar Kelimeler
amino acid Schiff base | enzyme inhibition | molecular docking | Zn(II) complexes